🇺🇸 FDA
Pipeline program

Gemcitabine+simvastatin

2008-07-065

Phase 2 small_molecule completed

Quick answer

Gemcitabine+simvastatin for Pancreatic Cancer is a Phase 2 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Samsung Bioepis NL B.V.
Indication
Pancreatic Cancer
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials